West Announces Second-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
West Pharma (WST) Tops Q2 EPS by 72c; Raises Outlook
July 29, 2021 6:44 AM EDTWest Pharma (NYSE: WST) reported Q2 EPS of $2.46, $0.72 better than the analyst estimate of $1.74. Revenue for the quarter came in at $723.6 million versus the consensus estimate of $669.38 million.
GUIDANCE:
West Pharma sees FY2021 EPS of $8.05-$8.20, versus the consensus of... More
